Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 18, Issue 4, Pages 473-489
Publisher
Informa Healthcare
Online
2014-02-13
DOI
10.1517/14728222.2014.888415
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deficient TACI Expression on B Lymphocytes of Newborn Mice Leads to Defective Ig Secretion in Response to BAFF or APRIL
- (2014) S. Kanswal et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Increased CD4+Foxp3+ T Cells in BAFF-Transgenic Mice Suppress T Cell Effector Responses
- (2014) S. Walters et al. JOURNAL OF IMMUNOLOGY
- Development of Systemic Lupus Erythematosus in NZM 2328 Mice in the Absence of any Single BAFF Receptor
- (2013) Chaim O. Jacob et al. ARTHRITIS AND RHEUMATISM
- B-Cell Targeted Therapies in Systemic Lupus Erythematosus
- (2013) Philip R. Harvey et al. BIODRUGS
- The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
- (2013) Fabien B. Vincent et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The TACI Receptor Regulates T-Cell-Independent Marginal Zone B Cell Responses through Innate Activation-Induced Cell Death
- (2013) William A. Figgett et al. IMMUNITY
- Genetic susceptibility to SLE: Recent progress from GWAS
- (2013) Yong Cui et al. JOURNAL OF AUTOIMMUNITY
- Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus
- (2013) Jordan V. Price et al. JOURNAL OF CLINICAL INVESTIGATION
- CVID-associated TACI mutations affect autoreactive B cell selection and activation
- (2013) Neil Romberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation
- (2013) Radhika Goenka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Many Faces of TRAF Molecules in Immune Regulation
- (2013) G. A. Bishop JOURNAL OF IMMUNOLOGY
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- Mcl-1 is essential for the survival of plasma cells
- (2013) Victor Peperzak et al. NATURE IMMUNOLOGY
- No Evidence That Soluble TACI Induces Signalling via Membrane-Expressed BAFF and APRIL in Myeloid Cells
- (2013) Josquin Nys et al. PLoS One
- Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort
- (2013) E. M. McCarthy et al. RHEUMATOLOGY
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
- (2012) Susan Manzi et al. ANNALS OF THE RHEUMATIC DISEASES
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice
- (2012) Narendiran Rajasekaran et al. ARTHRITIS AND RHEUMATISM
- IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells
- (2012) Taku Yoshio et al. ARTHRITIS AND RHEUMATISM
- TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes
- (2012) Monica Martinez-Gallo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of Belimumab on Vaccine Antigen Antibodies to Influenza, Pneumococcal, and Tetanus Vaccines in Patients with Systemic Lupus Erythematosus in the BLISS-76 Trial
- (2012) W. WINN CHATHAM et al. JOURNAL OF RHEUMATOLOGY
- Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
- (2012) DJ Wallace et al. LUPUS
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- Murine BAFF expression is up-regulated by estrogen and interferons: Implications for sex bias in the development of autoimmunity
- (2012) Ravichandran Panchanathan et al. MOLECULAR IMMUNOLOGY
- Selective APRIL Blockade Delays Systemic Lupus Erythematosus in Mouse
- (2012) Bertrand Huard et al. PLoS One
- Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival
- (2012) X. Ou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice
- (2011) Chaim O. Jacob et al. ARTHRITIS AND RHEUMATISM
- Role of TNFRSF13B variants in patients with common variable immunodeficiency
- (2011) N. Martinez-Pomar et al. BLOOD
- TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow
- (2011) S. Tsuji et al. BLOOD
- Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI
- (2011) Amaya I. Wolf et al. JOURNAL OF CLINICAL INVESTIGATION
- B Cell Maturation Antigen Deficiency Exacerbates Lymphoproliferation and Autoimmunity in Murine Lupus
- (2011) C. Jiang et al. JOURNAL OF IMMUNOLOGY
- Cellular Competition Independent of BAFF/B Lymphocyte Stimulator Results in Low Frequency of an Autoreactive Clonotype in Mature Polyclonal B Cell Compartments
- (2011) N. Nikbakht et al. JOURNAL OF IMMUNOLOGY
- B Cell and BAFF Dependence of IFN- -Exaggerated Disease in Systemic Lupus Erythematosus-Prone NZM 2328 Mice
- (2011) N. Jacob et al. JOURNAL OF IMMUNOLOGY
- Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
- (2011) M. Kreuzaler et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- BAFF Promotes Th17 Cells and Aggravates Experimental Autoimmune Encephalomyelitis
- (2011) Xiaohui Zhou et al. PLoS One
- Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case–control study
- (2011) Gro Ø. Eilertsen et al. RHEUMATOLOGY
- Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity
- (2010) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
- (2010) Y. Iwata et al. BLOOD
- Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices
- (2010) M. Hegazy et al. CLINICAL IMMUNOLOGY
- Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses
- (2010) Claudia Bossen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- B-cell targeted therapies in human autoimmune diseases: an updated perspective
- (2010) Michael J. Townsend et al. IMMUNOLOGICAL REVIEWS
- The Structure of the TNFRSF13C Promoter Enables Differential Expression of BAFF-R during B Cell Ontogeny and Terminal Differentiation
- (2010) S. A. Mihalcik et al. JOURNAL OF IMMUNOLOGY
- Regulation of the B Cell Receptor Repertoire and Self-Reactivity by BAFF
- (2010) M. Ota et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10-Producing Regulatory B Cells
- (2010) M. Yang et al. JOURNAL OF IMMUNOLOGY
- Protective and Pathogenic Roles for B Cells during Systemic Autoimmunity in NZB/W F1 Mice
- (2010) K. M. Haas et al. JOURNAL OF IMMUNOLOGY
- Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
- (2010) R. Watanabe et al. JOURNAL OF IMMUNOLOGY
- B-lymphocyte-induced maturation protein1 up-regulates the expression of B-cell maturation antigen in mouse plasma cells
- (2010) Shaoli Deng et al. MOLECULAR BIOLOGY REPORTS
- The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88
- (2010) Bing He et al. NATURE IMMUNOLOGY
- B-lymphocyte stimulator/a proliferation-inducing ligand heterotrimers are elevated in the sera of patients with autoimmune disease and are neutralized by atacicept and B cell maturation antigen-immunoglobulin
- (2010) Stacey R Dillon et al. ARTHRITIS RESEARCH & THERAPY
- Rituximab and lupus: Good in real life, bad in controlled trials. comment on the article by Lu et al
- (2009) Manuel Ramos-Casals et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Novel evidence-based systemic lupus erythematosus responder index
- (2009) Richard A. Furie et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor
- (2009) L. Zhang et al. JOURNAL OF NEUROSCIENCE
- B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans
- (2009) K. Warnatz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus
- (2008) J Morel et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
- (2008) E. Belnoue et al. BLOOD
- TRAF2 and TRAF3 Signal Adapters Act Cooperatively to Control the Maturation and Survival Signals Delivered to B Cells by the BAFF Receptor
- (2008) Sandra Gardam et al. IMMUNITY
- TGF- 1 and IFN- stimulate mouse macrophages to express BAFF via different signaling pathways
- (2008) H.-A Kim et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling
- (2008) Jason E Stadanlick et al. NATURE IMMUNOLOGY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
- (2008) J. L. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
- (2008) Richard Furie et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started